[Prev][Next][Index][Thread]

Re: BST a flop?



In Article <v02130501aeb01a84a473@[205.184.16.234]>, whblake@ix.netcom.com
(Bill Blake) wrote:
>Ann -
>
>Another genetic engineering failure: the Flavr Savr tomato. Calgene was
>engineering it for years, and heavily in debt before the tomato hit the
>market. There's no way they could have made back all they spent.
>
>- Bill

Is this your own hunch, or can you cite some data to support your conclusion?
I believe that the product is patented and approved by the regulatory
agencies. It's essentially a new product. Calgene still has plenty of time
to make a profit on it.


References: